Terms: = Gastric cancer AND PML, TRIM19, 5371, ENSG00000140464, MYL, PP8675, RNF71 AND Treatment
6 results:
1. Trastuzumab biosimilars vs trastuzumab originator in the treatment of HER2-positive breast cancer: a systematic review and network meta-analysis.
Liu T; Liu D; Jin Y; Dong M
Immunopharmacol Immunotoxicol; 2022 Dec; 44(6):809-815. PubMed ID: 35708278
[TBL] [Abstract] [Full Text] [Related]
2. The efficacy and safety of targeted therapy with or without chemotherapy in advanced gastric cancer treatment: a network meta-analysis of well-designed randomized controlled trials.
Zhao TT; Xu H; Xu HM; Wang ZN; Xu YY; Song YX; Yin SC; Liu XY; Miao ZF
Gastric Cancer; 2018 May; 21(3):361-371. PubMed ID: 29455269
[TBL] [Abstract] [Full Text] [Related]
3. Patterns of Initial Recurrence in gastric Adenocarcinoma in the Era of Preoperative Therapy.
Ikoma N; Chen HC; Wang X; Blum M; Estrella JS; Fournier K; Mansfield P; Ajani J; Badgwell BD
Ann Surg Oncol; 2017 Sep; 24(9):2679-2687. PubMed ID: 28332034
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis.
Ichikawa H; Yoshida A; Kanda T; Kosugi S; Ishikawa T; Hanyu T; Taguchi T; Sakumoto M; Katai H; Kawai A; Wakai T; Kondo T
Cancer Sci; 2015 Jan; 106(1):115-24. PubMed ID: 25457157
[TBL] [Abstract] [Full Text] [Related]
5. Knockdown of inwardly rectifying potassium channel Kir2.2 suppresses tumorigenesis by inducing reactive oxygen species-mediated cellular senescence.
Lee I; Park C; Kang WK
Mol Cancer Ther; 2010 Nov; 9(11):2951-9. PubMed ID: 20841375
[TBL] [Abstract] [Full Text] [Related]
6. Loss of promyelocytic leukemia protein in human gastric cancers.
Lee HE; Jee CD; Kim MA; Lee HS; Lee YM; Lee BL; Kim WH
Cancer Lett; 2007 Mar; 247(1):103-9. PubMed ID: 16713073
[TBL] [Abstract] [Full Text] [Related]
